1.Actual situation and prescribing patterns of opioids by pain physicians in South Korea
Min Jung KIM ; Ji Yeon KIM ; Yun Hee LIM ; Sung Jun HONG ; Jae Hun JEONG ; Hey Ran CHOI ; Sun Kyung PARK ; Jung Eun KIM ; Min Ki LEE ; Jae Hun KIM
The Korean Journal of Pain 2022;35(4):475-487
Background:
Use of opioids for chronic intractable pain is increasing globally, and their proper use can improve patients’ quality of life. In contrast, opioid use disorders, such as abuse or addiction, caused by prescribing opioids, are a worldwide issue. This study aimed to understand current opioid prescribing patterns and pain physicians’ experiences with opioid use in South Korea.
Methods:
Pain physicians in 42 university hospitals in South Korea were asked to complete anonymous questionnaires regarding opioid prescriptions.
Results:
A total of 69 surveys were completed. Most pain physicians started prescribing opioids at a pain score of 7/10 and aimed to reduce pain by 50%. Most physicians (73.1%) actively explained the prescribed medications and possible side effects, and 61.2% of physicians preferred the prescription interval of 4 weeks.Immediate-release opioids were the most popular treatment for breakthrough pain (92.6%). The most common side effect encountered by physicians was constipation (43.3%), followed by nausea/vomiting (34.3%). Of the physicians, 56.5% replied that addiction and misuse prevalences were less than 5%. However, the most concerning side effect was addiction (33.0%).
Conclusions
The survey results showed that the prescribing patterns of pain physicians generally followed Korean guidelines. Physicians were most interested in the safety and effectiveness of opioid prescriptions. They were most concerned about respiratory depression and abuse or addiction. A significant number of physicians agreed that the NHIS regulations needed improvement for patient convenience and safe and effective treatment, though there were pros and cons of the NHIS restrictions on prescription conditions.
2.Computed Tomography (CT) Protocols Associated with Cardiac and Bone Single-Photon Emission Computed Tomography/CT (SPECT/CT) in Korea
Eun Jeong LEE ; Ji Young KIM ; Jung Mi PARK ; Bong-Il SONG ; Hongyoon CHOI ; Hye-kyeong SHIM ; Hey Lim PARK ; Ho-Young LEE ; Kyung Jae LEE ; Joon-Kee YOON ; Seongho SEO ; Seong Min KIM ; Soo Bin PARK ; Young Seok CHO ; Seong Hoon KIM
Nuclear Medicine and Molecular Imaging 2020;54(3):139-146
Purpose:
Single-photon emission computed tomography/computed tomography (SPECT/CT) is an advanced hybrid nuclear medicine technology that generates both functional and anatomical images in a single study. As utilization of SPECT/CT in Korea has been increasing, the purpose of this study was to survey its application of cardiac and skeletal SPECT/CT imaging for protocol optimization.
Methods:
We surveyed CT protocols established for cardiac and skeletal SPECT/CT. We searched the guidelines for the CT protocols for SPECT/CT and reviewed the literature recently published.
Results:
Among 36 hybrid SPECT scanners equipped with four or more multi-channel detector CTs (MDCTs), 18 scanners were used to perform cardiac studies at both very low current CT (30–80 mA; 11.1%) and ultra-low current CT (13–30 mA; 88.9%). Among the 33 canners, very low current (≤ 80 mA) CT or low current CT (80–130 mA) was used in 23.5%, and 41.8% for spine disorders, and in 36.4% or 30.3% for foot/ankle disorders, respectively. In the CT reconstructions, slice thickness of 5 mm for cardiac studies was most commonly used (94.4%); thinner slices (0.6–1.0 mm) for spine and foot/ankle studies were used in 24.2% and 45.5%, respectively. We also reviewed the international guidelines.
Conclusions
The results and current recommendations will be helpful for optimizing CT protocols for SPECT/CT. Optimization of SPECT/CT protocols will be required for generating the proper strategy for the specific lesions and clinical purpose.
3.Urinary transglutaminase 2 as a potent biomarker to predict interstitial fibrosis and tubular atrophy of kidney allograft during early posttransplant period in deceased donor kidney transplantation
Jee Yeon KIM ; Yu Mee WEE ; Monica Young CHOI ; Hey Rim JUNG ; Ji Yoon CHOI ; Hyun Wook KWON ; Joo Hee JUNG ; Yong Mee CHO ; Heounjeong GO ; Minkyu HAN ; Young Hoon KIM ; Duck Jong HAN ; Sung SHIN
Annals of Surgical Treatment and Research 2019;97(1):27-35
PURPOSE: Transglutaminase type 2 (TG2) is an extracellular matrix crosslinking enzyme with a pivotal role in kidney fibrosis. We tested whether quantification of urinary TG2 may represent a noninvasive method to estimate the severity of kidney allograft fibrosis. METHODS: We prospectively collected urine specimens from 18 deceased donor kidney transplant recipients at 1-day, 7-day, 1-month, 3-month, and 6-month posttransplant. In addition, kidney allograft tissue specimens at 0-day and 6-month posttransplant were sampled to analyze the correlation of urinary TG2 and kidney allograft fibrosis. RESULTS: Thirteen recipients had increased interstitial fibrosis and tubular atrophy (IFTA) scores at the 6-month protocol biopsy (IFTA group). The mean level of urinary TG2 in the IFTA group was higher compared to that of 5 other recipients without IFTA (no IFTA group). Conversely, the mean level of urinary syndecan-4 in the IFTA group was lower than levels in patients without IFTA. In the IFTA group, double immunofluorescent staining revealed that TG2 intensity was significantly upregulated and colocalizations of TG2/heparin sulfate proteoglycan and nuclear syndecan-4 were prominent, usually around tubular structures. CONCLUSION: Urinary TG2 in early posttransplant periods is a potent biomarker for kidney allograft inflammation or fibrosis.
Allografts
;
Atrophy
;
Biomarkers
;
Biopsy
;
Extracellular Matrix
;
Fibrosis
;
Humans
;
Inflammation
;
Kidney Transplantation
;
Kidney
;
Methods
;
Prospective Studies
;
Proteoglycans
;
Syndecan-4
;
Tissue Donors
;
Transplant Recipients
4.Relationship between atopy and bronchial hyperresponsiveness to indirect stimuli in asthmatic children.
Tae Young PARK ; Min Ju YI ; Woo Hyeok CHOI ; Su Yeong KIM ; Rita YU ; Ji Eun BAN ; Seong YANG ; Il Tae HWANG ; Hey Sung BAEK
Allergy, Asthma & Respiratory Disease 2017;5(2):83-91
PURPOSE: Both atopy and bronchial hyperresponsiveness (BHR) are characteristic features of asthma. Several BHR studies comparing groups of atopic and nonatopic asthmatics have reported conflicting results. The aim of this study was to compare BHR to indirect stimuli, such as mannitol or exercise, between atopic and nonatopic asthmatics in children. METHODS: We performed a retrospective analysis of data from 110 children with asthma, aged 6–18 years using skin prick tests, and serum total and specific IgE levels. Atopy degree was measured using the sum of graded wheal size or the sum of the allergen-specific IgE. Bronchial provocation tests (BPTs) using methacholine were performed on all subjects. BPTs using indirect simuli, including exercise and mannitol, were also performed. RESULTS: Asthma cases were classified as atopic asthma (n=83) or nonatopic asthma (n=27) from skin prick or allergen-specific IgE test results. There was no significant difference in the prevalence of BHR to mannitol or exercise between atopic and nonatopic asthmatics. Atopic asthma had a significantly lower postexercise maximum decrease in % forced expiratory volume in 1 second (FEV1) (geometric mean [95% confidence interval]: 31.9 [22.9–40.9] vs. 14.0 [9.4–18.6], P=0.015) and a methacholine PC20 (provocative concentration of methacholine inducing a 20% fall in FEV1) than nonatopic asthmatics (geometric mean [95% confidence interval]: 1.24 [0.60–1.87] ng/mL vs. 4.97 [3.47–6.47]) ng/mL, P=0.001), whereas mannitol PD15 (cumulative provocative dose causing a 15% fall in FEV1) was not significantly different between the 2 groups. CONCLUSION: There was no significant difference in the prevalence of BHR to mannitol or exercise between atopic and nonatopic asthmatics in children.
Asthma
;
Bronchial Provocation Tests
;
Child*
;
Forced Expiratory Volume
;
Humans
;
Immunoglobulin E
;
Mannitol
;
Methacholine Chloride
;
Prevalence
;
Retrospective Studies
;
Skin
5.Serum periostin levels and squamous cell carcinoma-related antigen levels in children with atopic dermatitis.
Woo Hyeok CHOI ; Tae Young PARK ; Su Yeong KIM ; Rita YU ; Ji Eun BAN ; Seong YANG ; Il Tae HWANG ; Hey Sung BAEK
Allergy, Asthma & Respiratory Disease 2017;5(2):73-78
PURPOSE: It was found that periostin and squamous cell carcinoma-related antigens (SCCAs) were strongly interleukin-13-inducible gene products. This study measures the serum periostin and SCCA levels in children suffering from atopic dermatitis (AD) and to evaluate the association between the severity of AD and their values. METHODS: Seventy AD children aged 1 month to 10 years were included in our study. Subjects were characterized as having atopic eczema (AE; n=55) or non-AE (NAE; n=15) by atopic sensitization. Serum SCCA and periostin levels were measured. RESULTS: The serum periostin levels were significantly higher in children with AE than in those with NAE (geometric mean [95% confidence interval]: 80.47 ng/mL [75.06–85.93 ng/mL] vs. 67.45 ng/mL [59.99–75.64] ng/mL, P=0.020). The serum concentrations of both SCCA1 and SCCA2 were significantly higher in children with AE than in those with NAE (geometric mean [95% confidence interval]: 1.401 [1.198–1.643] ng/mL vs. 0.969 [0.723–1.268] ng/mL, P=0.039 for SCCA1) (1.178 [0.974–1.455] ng/mL vs. 0.711 [0.540–0.994] ng/mL, P=0.025 for SCCA2). The serum periostin levels were significantly correlated with disease severity and with peripheral blood eosinophil counts. The SCCA levels were not significantly correlated with disease severity. Both SCCA1 and SCCA2 were significantly correlated with serum periostin levels and blood eosinophil counts. CONCLUSION: Serum periostin levels may be significantly correlated with disease severity and blood eosinophil counts in children with AD. Serum SCCA levels can be significantly correlated with serum periostin levels and blood eosinophil counts in children with AD.
Child*
;
Dermatitis, Atopic*
;
Eosinophils
;
Epithelial Cells*
;
Humans
6.Cardiovascular Safety Pharmacology of Sibutramine.
Jaesuk YUN ; Eunyong CHUNG ; Ki Hwan CHOI ; Dae Hyun CHO ; Yun Jeong SONG ; Kyoung Moon HAN ; Hey Jin CHA ; Ji Soon SHIN ; Won Keun SEONG ; Young Hoon KIM ; Hyung Soo KIM
Biomolecules & Therapeutics 2015;23(4):386-389
Sibutramine is an anorectic that has been banned since 2010 due to cardiovascular safety issues. However, counterfeit drugs or slimming products that include sibutramine are still available in the market. It has been reported that illegal sibutramine-contained pharmaceutical products induce cardiovascular crisis. However, the mechanism underlying sibutramine-induced cardiovascular adverse effect has not been fully evaluated yet. In this study, we performed cardiovascular safety pharmacology studies of sibutramine systemically using by hERG channel inhibition, action potential duration, and telemetry assays. Sibutramine inhibited hERG channel current of HEK293 cells with an IC50 of 3.92 muM in patch clamp assay and increased the heart rate and blood pressure (76 Deltabpm in heart rate and 51 DeltammHg in blood pressure) in beagle dogs at a dose of 30 mg/kg (per oral), while it shortened action potential duration (at 10 muM and 30 muM, resulted in 15% and 29% decreases in APD50, and 9% and 17% decreases in APD90, respectively) in the Purkinje fibers of rabbits and had no effects on the QTc interval in beagle dogs. These results suggest that sibutramine has a considerable adverse effect on the cardiovascular system and may contribute to accurate drug safety regulation.
Action Potentials
;
Animals
;
Blood Pressure
;
Cardiovascular System
;
Counterfeit Drugs
;
Dogs
;
Heart Rate
;
HEK293 Cells
;
Inhibitory Concentration 50
;
Pharmaceutical Preparations
;
Pharmacology*
;
Purkinje Fibers
;
Rabbits
;
Telemetry
7.General anesthesia versus sedation with dexmedetomidine for thoracic endovascular aortic repair in 38 patients in multicenter experiences: A retrospective study.
Hey Ran CHOI ; Dae Won LEE ; Kyung Woo KIM ; Si Ra BANG ; Sun Kyung MIN ; Min Kyung OH ; Ji Yeon KIM ; Young Jin RO ; Yoon Ji CHOI
Anesthesia and Pain Medicine 2014;9(3):193-200
BACKGROUND: Endovascular stent graft placement is a useful treatment option in lesions of the thoracic aorta. The aim of this study was to assess the possibility of sedation with dexmedetomidine compared with general anesthesia in patients undergoing thoracic endovascular aortic repair (TEVAR) in a multi-center clinical trial. METHODS: Data from 38 patients with thoracic aorta lesions treated by TEVAR between April 2010 and November 2013 were retrospectively collected at two hospitals. General anesthesia or sedation with dexmedetomidine was determined according to the hospital. Demographics, anesthetic recordings, and complications were reviewed. RESULTS: Stent graft placement was technically successful in all patients. There were no events during the anesthetic period. A total of 38 patients underwent TEVAR; 29 patients received general anesthesia, and 9 received sedation. Dexmedetomidine sedation (loading dose: 0.5-1.0 microg/kg for 10 min, maintenance: 0.2-0.8 microg/kg/h) was successfully performed without anesthesia-related complications or mortality. During the procedure, mean arterial pressure, heart rate, and saturation of peripheral oxygen were not statistically different between general anesthesia and dexmedetomidine sedation. CONCLUSIONS: In our study, TEVAR under sedation with dexmedetomidine was shown to be a feasible procedure that was well tolerated without specific complications.
Anesthesia, General*
;
Aorta, Thoracic
;
Arterial Pressure
;
Blood Vessel Prosthesis
;
Demography
;
Dexmedetomidine*
;
Heart Rate
;
Humans
;
Mortality
;
Oxygen
;
Retrospective Studies*
8.Sensitization patterns to common allergens in Korean children younger than 6 years of age presenting with typical symptoms or signs of allergic diseases: a single center study.
Jung Won YOON ; Sang Min LEE ; Joon Hwan KIM ; Na Yeon KIM ; Ji Hyeon BAEK ; Hey Sung BAEK ; Hye Mi JEE ; Hyeung Yoon KIM ; Sun Hee CHOI ; Ki Eun KIM ; Hye Yung YUM ; Man Yong HAN ; Jintack KIM ; Youn Ho SHIN
Allergy, Asthma & Respiratory Disease 2014;2(4):272-276
PURPOSE: Population studies have reported that sensitization to inhalant allergens is rare in young children; however, most subjects in those studies had little or no symptoms or signs highly suggestive of allergic diseases. The aim of the present study was to assess the prevalence of sensitization to inhalant allergens in young children with symptoms and/or signs of allergic disease. METHODS: We analyzed the results of all specific IgE tests performed at our hospital laboratory in children younger than 6 years presenting with symptoms and/or signs highly suggestive of allergic diseases between 2008 and 2013. Specific IgE tests for Dermatophagoides pteronyssinus, Dermatophagoides farinae, Alternaria alternata, German cockroach, cat dander, egg white or egg yolk, milk, peanut, and soybean were performed on 295 children; a specific IgE concentration > or =0.35 or > or =0.2 IU/mL was considered positive. We also compared allergen sensitization rates using the two cutoff values. RESULTS: One hundred eighty-one children (61.4%) were positive to at least 1 allergen tested and 53 children (18.9%) were positive to at least 1 inhalant allergen when a specific IgE concentration > or =0.35 IU/mL was considered positive. The children were more likely to have asthma or allergic rhinitis when they were sensitized to any inhalant allergen, particularly house dust mites. The prevalence of sensitization to inhalant allergens increased with age (P<0.001). There was no significant difference in the prevalence of polysensitization among different age groups, but sensitization to both inhalant and food allergens significantly increased with age. CONCLUSION: Our results suggest that specific IgE tests to common inhalant allergens, particularly the house dust mites, may be considered when performing blood screening tests for young children presenting with symptoms and/or signs of allergic diseases.
Allergens*
;
Alternaria
;
Animals
;
Asthma
;
Blattellidae
;
Cats
;
Child*
;
Dander
;
Dermatophagoides farinae
;
Dermatophagoides pteronyssinus
;
Egg White
;
Egg Yolk
;
Humans
;
Immunoglobulin E
;
Laboratories, Hospital
;
Mass Screening
;
Milk
;
Prevalence
;
Pyroglyphidae
;
Rhinitis
;
Soybeans
9.PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices.
Jun KIM ; Ji Won BYUN ; Insup CHOI ; Beomsue KIM ; Hey Kyeong JEONG ; Ilo JOU ; Eunhye JOE
Experimental Neurobiology 2013;22(1):38-44
Parkinson's disease (PD) is the second most common neurodegenerative motor disease caused by degeneration of dopaminergic neurons in the substantia nigra. Because brain inflammation has been considered a risk factor for PD, we analyzed whether PTEN induced putative kinase 1 (PINK1), an autosomal recessive familial PD gene, regulates brain inflammation during injury states. Using acutely prepared cortical slices to mimic injury, we analyzed expression of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin (IL)-1beta, and IL-6 at the mRNA and protein levels. Both mRNA and protein expression of these cytokines was higher at 6-24 h after slicing in PINK1 knockout (KO) slices compared to that in wild-type (WT) slices. In serial experiments to understand the signaling pathways that increase inflammatory responses in KO slices, we found that IkappaB degradation was enhanced but Akt phosphorylation decreased in KO slices compared to those in WT slices. In further experiments, an inhibitor of PI3K (LY294002) upstream of Akt increased expression of pro-inflammatory cytokines. Taken together, these results suggest that PINK1 deficiency enhance brain inflammation through reduced Akt activation and enhanced IkappaB degradation in response to brain injury.
Brain
;
Brain Injuries
;
Cytokines
;
Dopaminergic Neurons
;
Encephalitis
;
Hydrazines
;
Inflammation
;
Interleukin-6
;
Interleukins
;
Parkinson Disease
;
Phosphorylation
;
Phosphotransferases
;
Risk Factors
;
RNA, Messenger
;
Substantia Nigra
;
Tumor Necrosis Factor-alpha
10.Usefulness of Real-time Measurement of Colonoscopy Withdrawal Time during Fellow Training.
Chung Hyun TAE ; Sung Ae JUNG ; Seung Jung JUN ; Sun Hee ROH ; Ju Young CHOI ; Min Jung KANG ; Ji Min JUNG ; Seong Eun KIM ; Ki Nam SHIM ; Hey Kyung JUNG ; Tae Hun KIM ; Kwon YOO ; Il Hwan MOON
Korean Journal of Gastrointestinal Endoscopy 2011;42(6):356-360
BACKGROUND/AIMS: Attempts to increase colonoscopy withdrawal time have been the topic of several recent publications. We assessed whether the real-time measurement of withdrawal time affected the withdrawal time and polyp detection rate. METHODS: Real-time colonoscopy withdrawal time was measured in 197 subjects in a study group and 184 subjects comprised a control group without real-time measurements. Colonoscopies were performed by four endoscopy specialists and three fellows during their first year of training. Withdrawal time, clinical features, bowel preparation, and polyp detection rates were comparatively analyzed. RESULTS: No significant differences in age, gender, bowel preparation, or polyp history were found in the two groups. Withdrawal time was significantly higher in the study group than that in the control group when a fellow performed the withdrawal. However, polyp detection rate did not significantly increase in the study group, regardless of physician. CONCLUSIONS: Real-time measurement of colonoscopy withdrawal time did not increase polyp detection rate, but the withdrawal time was significantly higher when a fellow performed the withdrawal phase than when a specialist performed withdrawal. Therefore, the real-time measurement of colonoscopy withdrawal time seems to be a useful tool for fellow training.
Colonoscopy
;
Endoscopy
;
Polyps
;
Quality Control
;
Specialization

Result Analysis
Print
Save
E-mail